Monday, April 26, 2021

#Cannabis #Stock News: Phyto Extractions(TM) (CSE: $XTRX.C) (Frankfurt:D2EP) Engages Independent Trading Group Inc. for Market-Making; @adastra_labs

#Cannabis #Stock News: Phyto Extractions(TM) (CSE: $XTRX.C) (Frankfurt:D2EP) Engages Independent Trading Group Inc. for Market-Making; @adastra_labs

 


LANGLEY, BC  April 26, 2021 – Investorideas.com Newswire -  Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt: D2EP) ("Phyto Extractions™" or the "Company) is pleased to announce that it subject to regulatory approval, has retained Independent Trading Group (ITG) to provide market-making services in compliance with the policies and guidelines of the Canadian Securities Exchange (CSE) and other applicable legislation.

 


Read this news, featuring XTRX in full at https://www.investorideas.com/CO/XTRX/news/2021/04262Independent-Trading-Group.asp

 

ITG will trade shares of Phyto Extractions Inc. on the Canadian Securities Exchange (CSE) and other trading venues with the objective of maintaining a reasonable market and improving the liquidity of Phyto Extractions Inc. Under the terms of the agreement, ITG will receive $5,000 per month payable on the first business day of each month. The engagement is effective Apr. 26, 2021, and has an initial term of three months. Thereafter, the engagement will automatically renew for successive one-month terms until terminated by either party upon 30 days prior written notice. There are no performance factors contained in the agreement, and ITG will not receive shares or options as compensation.

 

About Independent Trading Group (ITG)

ITG is an independent, privately-held broker-dealer based in Toronto, Ont., that provides a wide range of financial and investment services, and is registered with the Canadian Securities Exchange, NEO, Toronto Stock Exchange and TSX-V along with the Investment Industry Regulatory Organization of Canada (IIROC).

 

About Phyto Extractions™

Phyto Extractions™ is an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction and products, no cultivation), Sales (extracts, topicals, and edibles), and R&D through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc.

 

ON BEHALF OF THE BOARD

PHYTO EXTRACTIONS INC. (CSE: XTRX)

 

Contact: J. Scott Munro, President, CEO & Director (Chairman)

Phone: (778) 715-5011

Email: scott@adastralabs.ca

 

Forward-Looking Information:

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking information in this news release includes statements with respect of the proposed name change, proposed consolidation, the closing of the private placement and the use of proceeds thereof. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks inherent in the cannabis extraction sector in general; (iii) inability to close the private placement for any reason, or in the amounts expected by the Company; and (iv) other factors beyond the control of the Company. There can be no assurance that ITG market-making services will result in increased trading, liquidity or share price. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

 

The CSE has not reviewed or approved of any contents of this news release.

 

SOURCE: Phyto Extractions Inc.

Phyto Extractions Inc. (CSE:XTRX) (Frankfurt:D2EP) is a featured Cannabis stock on Investorideas.com

 

Visit profile page

 

Disclaimer/Disclosure:

Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: XTRX is a featured cannabis stock on Investorideas.com and the cannabis potcast effective April 14 More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

 



Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

 

Investor Ideas #Potcast 557, #Cannabis News and #Stocks on the Move; Interview with Alex Gettlin, Host of the “Highly Unlikely” Podcast

 



 

 

 

Investor Ideas #Potcast 557, #Cannabis News and #Stocks on the Move; Interview with Alex Gettlin, Host of the “Highly Unlikely” Podcast

 

Podcast sponsored by Phyto Extractions Inc. (CSE: $XTRX.C)

 

Delta, Kelowna, BC, April 26, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/042321-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/04261Interview-Alex-Gettlin.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

In today’s podcast Investorideas interviews Alex Gettlin, Comedian and Host of the new “Highly Unlikely” Podcast, where discussed the launch of the show, how Alex chose both his guests and the strains of cannabis for the show and what it’s like having a job where you get to get high for work.

 

Highly Unlikely is one of Wikileaf’s new podcast series being launched along with Hip Hop History High and Wikileaf Audio. Wikileaf is a price comparison platform for recreational and medicinal cannabis consumers and provides consumers with instant price comparison among dispensaries in their immediate vicinity.

Since its inception in 2014, Wikileaf's mission has been to empower the cannabis consumer and achieves this through transparency in pricing when shopping for dispensaries or deliveries and transparency in information whether researching strains, brands, industry news or jobs.

 

Highly Unlikely is described as, “have you ever gone down a rabbit hole and discovered facts about reality that blow your mind? Well, so do we, the only difference is on Highly Unlikely, we do it stoned.”

 

Alex Gettlin commented on the show and getting paid to get high saying, “it definitely is fun to think of my life 10 years ago and the sort of stigma around smoking weed, and now my creative endeavors are becoming successful largely in part due to cannabis. For me, I use it for two reasons; one it helps me sleep at night, a nice Indica really helps relax me, and the other one I really enjoy is a nice Sativa that helps me go into those weird corners of my brain and come up with interesting ideas. I think it’s really helped my own creativity and curiosity. It’s really cool to have a job to literally get paid to smoke weed and talk about crazy and wild facts from all over the Internet.”

 

Season 1 of Highly Unlikely launched recently on 4/20 and will have eight episodes featuring Brent Pella, Kate Quigley, Slink Jonhson, Ben Gleib, Armando Torres, Chirs Cope, Alex Hooper and Chuante Wayans.

 

Gettlin commented on some of the more interesting and confusing elements of the cannabis industry he came across while prepping for the show mentioning, “this is the first time I’ve actually done anything involved with the business end of the cannabis world. It’s been a little frustrating learning how unclear all the rules are around social media platforms and cannabis use and what you can put where. I also learned that because it’s federally illegal still, of all of the financial troubles around the business end of cannabis, investors and entrepreneurs. I’m not an expert but just common sense to me seems that you have this incredible market, the sciences shows this isn’t a major threat to people’s health like cigarettes or alcohol is, it’s an incredible opportunity to create jobs, so why wouldn’;t you make it as easy as possible for folks to do this and build revenue for communities. On the cool side, learning how nuanced and convoluted all the different strains are, and how when they grow the plants ,the females create the THC.”

 

Gettlin continued to discuss possible future guests for the podcast, his own cannabis and psychedelic experiences and even eventually including psychedelics in the show's concept in the future.

 

To check out the first two episodes from Highly Unlikely click here.

https://podcasts.wikileaf.com/show/highly-unlikely/

 

Once again, today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Friday, April 23, 2021

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: EMH) Confirms Effective Listing Date on Canadian Securities Exchange

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: EMH) Confirms Effective Listing Date on Canadian Securities Exchange

Investor Ideas #Potcasts 556, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (CSE: $MEDI.C), (CSE: $IKNK.U.C) (TSXV: $HITI.V) (OTCQB: $HITIF)

 



 

 

Investor Ideas #Potcasts 556, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (CSE: $MEDI.C), (CSE: $IKNK.U.C) (TSXV: $HITI.V) (OTCQB: $HITIF)

 

Delta, Kelowna, BC, April 23, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/042321-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/04231XTRX-MEDI-IKNK-HITI.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

In today’s podcast we look at a few private and public company announcements.

 

Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) announced that it has entered into a letter of intent to acquire 100% of all issued and outstanding shares of Integrated Rehab and Performance Ltd. (“IRP”). Based in Victoria, BC, IRP operates Canada’s first and only multidisciplinary physical therapy clinic exclusively for patients who are past or present personnel of the Canadian Armed Forces or Royal Canadian Mounted Police, and first responders (e.g., firefighters, law enforcement officers, paramedics, EMTs, etc.).

Under the arrangement contemplated in the LOI, IRP’s practice would expand with the addition of new clinics in British Columbia, as well as the introduction of ketamine treatments to IRP’s offerings to its patients. IRP’s principal facility is located near the Westshore Town Centre in Victoria, BC, with service offerings including: physiatry; occupational therapy; physiotherapy; kinesiology; massage therapy; and nutrition. The clinic’s approach is to establish a 12-week improvement plan for each of its patients by holistically assessing existing and potential areas of concern and formulating a goal-oriented strategy . IRP is an approved healthcare service provider of Veterans Affairs Canada (VAC) through its claims administrator Medavie Blue Cross.

 

More information about IRP can be found on its website: https://veteranrehabandperform.com/

 

MEDI intends to assist IRP with the potential addition of psychedelic-assisted treatments, including ketamine assisted psychotherapy to its range of therapies, subject to required compassionate and Health Canada exemptions. Several clinics in the United States, some of which are also pending acquisition by MEDI as announced in recent press releases, have begun offering ketamine infusions to treat conditions such as depression and post-traumatic stress disorder (PTSD). In a 2019 CBC Radio segment, the potential use of ketamine to restore synaptic connections in the brain eroded by stress was explored by medical experts, along with similar benefits which could be had through the administration of other psychedelics (e.g., LSD, psilocybin).

 

“There is considerable use-case of psychedelic-assisted treatments in the Canadian healthcare ecosystem. IRP has done a great job in providing specialized wellness services for veteran and first responder patients in British Columbia. We look forward to partnering with IRP to introduce innovative treatment offerings and expand its network as they continue to improve quality of life for patients who make invaluable contributions to Canadian society.” Robert Meister, CEO, commented, “As Canada continues to be a leader in alternative-medicines and treatments, our goal is to aggressively pursue Section 56 exemptions for veteran patients of IRP, in order to be able to offer access to psychedelic assisted therapy as an addition to their current treatment plans. IRP patients should have every right to access leading medicines that are proving to be transformational and therapeutic by nature.”

 

Pursuant to the LOI, MEDI would acquire 100% of IRP’s issued and outstanding shares in exchange for $1,000,000, payable in common shares in the capital of the Company (the “Consideration Shares”). The Consideration Shares shall be issued on the date that the transaction closes (the “Closing Date”) and shall be subject to a voluntary lockup for a period of 18 months, released to the Vendor as follows:

      five (5%) percent will be freely tradable on the Closing Date; and

      fifteen and eighty-three hundredths (15.83%) percent released quarterly over six quarters from the Closing Date.

 

Furthermore, the LOI provides for a series of bonuses payable in common shares of MEDI (the “Milestone Shares”) upon IRP successfully reaching certain milestones, as outlined below.

Milestone Description

Deadline

Bonus Payable

Two new IRP clinics opened and operational with at least one registered patient at each clinic

September 30, 2021

200,000 MEDI common shares

Total gross revenue from all IRP clinics meets or exceeds CAD $2,000,000 for IRP’s 2022 fiscal year

First day of IRP’s 2023 fiscal year

250,000 MEDI common shares

Active studies of wearable physical therapy technology at two or more IRP clinics with a minimum of 20 Canadian Armed Forces veterans as participants

----

100,000 MEDI common shares

Facilitate or broker one clinical or academic study of the benefits of psychedelic intervention treatments

----

100,000 MEDI common shares

Referral of 50 patients to internal psychedelic clinics

----

50,000 MEDI common shares

 

The Consideration Shares and Milestone Shares shall be issued based on the volume weighted average trading price (VWAP) of the Company’s common shares for the 10 days preceding the Closing Date or the date on which the shares are earned, as the case may be. All Milestone Shares will be subject to a mandated trading restriction period of four months and one day following issuance of such shares.

 

As a condition of closing the acquisition, IRP’s current Chief Executive Officer, Steven Inglefield, will remain in his current position on a two-year contract commencing on the Closing Date, with an option to extend at the Company’s election. The executive contract shall additionally contain a standard non-compete clause, the grant of 200,000 stock options of MEDI, and a 10% cash bonus payable on annual net profit.

 

“We are thrilled to be collaborating with Myconic Capital, while providing innovative solutions to successfully improve the current care plans for military veterans, first responders and their families,” Steven Inglefield, CEO, IRP stated. “This strategic partnership allows us to leverage the platform and serves as a catalyst for R&P’s growth across Canada, as it enters into new markets and areas of treatment. As we continue to foster existing relationships with patient advocacy groups, we are confident our developments with treatment plans will allow for further options for those dealing with trauma and mental health challenges.”

 

The completion of the acquisition is subject to terms and conditions which include but are not limited to the execution of a definitive agreement, completion of satisfactory due diligence, the delivery and satisfactory review of the financial statements of IRP, and the approval of the transaction by the boards of directors of each of MEDI and IRP.

 

Ikänik Farms, Inc. (CSE: IKNK.Uannounced that its wholly owned, Colombian subsidiary Pideka SAS ("Pideka"), has completed the registration and commercialization process of six cannabis-based cosmetic products through the National Institute of Drug and Food Surveillance (INVIMA), the governing body in Colombia responsible new product registrations.

 

"We are excited to open the door to multiple countries concurrent with our product registrations and look forward to better serving the Latin American markets in the near future." said Brian Baca, CEO of Ikänik Farms.

 

The product suite is comprised of cosmetic products and offers skin care benefits, using the unique beneficial properties of cannabis derived oil. All products are designed with plant-derived oils and cultivated under strict quality and control standards, fortified with organic and natural ingredients to maximize the effect of the specific product and its purpose.

 

The products are medically authorized in three additional Latin American countries through the Colombian registration, opening the door for future product recognition and registration in the participating member countries of the Andean Pact, which includes Bolivia, Colombia, Ecuador and Peru. The Andean Pact accelerates the Company's ability to open multiple markets through a singular, unified registration.

 

"We are proud to have completed this major milestone and have positioned ourselves to be a leader and cornerstone of product quality within the global marketplace, with an initial emphasis in Latin America and Europe." said Borja Sanz de Madrid, President of Ikänik Farms International, Inc.

 

High Tide Inc. (TSXV: HITI) (OTCQB: HITIF), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, announced approximately (CAD) $775,000 in total retail gross revenues ("Total Sales") across all platforms on April 20, 2021 (4/20), representing an 80% increase from the previous Tuesday. The Company's Canadian bricks and mortar stores reported a 51% increase, while sales across its three e-commerce platforms, grasscity.com, smokecartel.com and cbdcity.com reported an increase of 201% percent over the previous Tuesday.

 

"We at High Tide have never forgotten our humble beginnings and the customers who have helped us grow from one small smoke shop into an international cannabis company operating 84 retail stores across Canada and two of the world's leading e-commerce platforms for consumption accessories," said Raj Grover, President and Chief Executive Officer. "Our commitment to cannabis culture and the cannabis community is deeply rooted in everything we do as a company. I'm thrilled to see that our loyal customers have once again delivered a record breaking 4/20 sales figure despite pandemic related restrictions in many jurisdictions," added Mr. Grover.

 

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRXannounced that it has received its R&D license addendum in Adastra Labs Inc. that will permit some limited human testing by licensed researchers administering or distributing cannabis to human research subjects using cannabis obtained from a holder of a license for processing in the final form of cannabis.

 

This R&D license addendum will permit the Company to conduct in-house human testing for taste of various cannabis products for assessment of taste, sights, smell, or touch of cannabis.

 

"We look forward to initiating human-studies and generating valuable consumer-based data to support our product development pipeline and continue delivering high-quality efficacious cannabis products to Canadians." Stated Dr. Kyle Boniface, PhD."

 

Once again, today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

 

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory